Clinical Correlation of Anatomical Location of Nonthrombotic Iliac Vein Lesion◊  by Medicine, Borislav Kheyson et al.
Table. Demographics and clinical characteristics
Variables
VAA
PObserved Repaired
Splenic
Patients, No. (%) 53 (47.3) 59 (52.7)
Age, mean 6 SD, years 66.8 6 13.3 54.3 6 15.6 <.0001
Females, No. (%) 41 (77.4) 33 (55.9) .017
Smoking, No. (%) 12 (23.5) 21 (36.2) .151
Diabetes, No. (%) 8 (15.7) 8 (13.6) .752
CRI, No. (%) 4 (7.8) 7 (11.9) .54
ESRD, No. (%) 1 (1.9) 1 (1.7) .999
HTN, No. (%) 35 (8.6) 29 (49.2) .039
HLD, No. (%) 15 (29.4) 17 (28.8) .945
CAD, No. (%) 5 (9.8) 7 (12.1) .767
COPD, No. (%) 0 (0) 6 (10.2) .999
CVA/TIA, No. (%) 2 (3.9) 1 (1.7) .596
Size, mean 6 SD mm 14.5 6 7.2 27.76 18.2 <.0001
Renal
Patients, No. (%) 11 (28.9) 27 (71.1)
Age, mean 6 SD years 60.7 6 16.2 52.6 6 16.5 .172
Females, No. (%) 9 (81.8) 20 (74.1) .611
Smoking, No. (%) 1 (9.1) 4 (14.81) .999
DM, No. (%) 0 (0.0) 2 (7.4) .999
CRI, No. (%) 1 (9.1) 0 (0.0) .289
ESRD, No. (%) 0 (0.0) 2 (7.4) .999
HTN, No. (%) 7 (63.6) 19 (70.4) .685
HLD, No. (%) 3 (27.3) 7 (26.9) .999
CAD, No. (%) 0 (0.0) 3 (11.1) .542
COPD, No. (%) 2 (7.4) 2 (7.4) .999
CVA/TIA, No. (%) 0 (0.0) 0 (0.0)
Size, mean 6 SD mm 14.7 6 8.4 22.3 6 7.9 .014
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary
disease; CRI, chronic renal insufﬁciency; CVA/TIA, cerebrovascular acci-
dent/transient ischemic attack; DM, diabetes mellitus; ESRD, end-stage
renal disease; HLD, hyperlipidemia; HTN, hypertension; SD, standard
deviation; VAA, visceral artery aneurysms.
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Volume 60, Number 3 Abstracts 835and Associates Inc, Flagstaff, Ariz) is an expanded polytetraﬂuoroethylene
(ePTFE) graft with an external nitinol stent on one end, designed for
remote venous implantation with high axillary dialysis access creation. We
recently used this device to treat femoral anastomotic disruptions in two
postoperative patients.
Methods: A 51-year-old woman presented with a massive groin he-
matoma and external bleeding on day 7 after a common femoral to
below-knee popliteal bypass with an in situ great saphenous vein graft.
She had no prior signs of infection. At exploration, dehiscence of the vein
graft was noted but no other evidence of infection. We deployed the stent
end of the graft into the external iliac artery through the femoral defect, and
anastomosed the graft end to the in situ graft and profunda femoris artery
distal to the dehiscence. The second patient was a 90-year-old man with
enlarging femoral artery anastomotic aneurysm after having undergone
prior endovascular exclusion. His comorbidities included severe aortic valve
stenosis and renal failure. Under tumescent anesthesia, we performed a right
groin exploration and discovered a 7-cm anastomotic aneurysm with local-
ized rupture and inﬂammatory changes extending into the iliac fossa. There
was no deﬁnite evidence of infection. We deployed the stent end of the Gore
Hybrid graft into the external iliac artery over an inﬂated balloon catheter
and extended proximally for persistent bleeding around the graft with a
10-mm  100-mm Viabahn (W.L. Gore and Associates). The ePTFE graft
was then anastomosed to the vein graft. Intraoperative gram stains were
negative in both patients, and sartorius muscle ﬂap closure was used.
Results: Both wounds healed and the grafts remain patent without
infection, now 6 and 3 months out from surgery, respectively.
Conclusions: The hybrid device offers an excellent off-the-shelf alter-
native for deﬁnitive treatment for anastomotic dehiscence while avoiding an
abdominal incision. It may also serve as bridge therapy in the setting of
infection to maintain distal perfusion until a suitable autogenous or extra-
anatomic revascularization can be achieved.
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Objective: Nonthrombotic iliac vein lesions are an active area of
research. The advantages of intravascular ultrasound (IVUS) imaging
include allowing the exact localization of these lesions. We chose to use
IVUS to explore the anatomical location of nonthrombotic iliac vein lesions
(NIVLs) and correlate it with clinical ﬁndings.
Methods: Over the course of 7 months, we performed 217 iliofe-
moral IVUS-assisted studies in 141 women and 76 men. The average 6
standard deviation age of examined population was 68 6 14 years (range,
22-96 years). We used IVUS intraoperatively to measure and record the
area of the involved iliofemoral veins. The measurement of stenosis was
compared with the adjacent nonstenotic iliofemoral veins. If >50% cross-
sectional area or diameter reduction was found by IVUS imaging, it was
treated with appropriate balloon size (range 10  40 to 16  60) and stent
(12-to 24-mm diameter  40-to 90-mm length). We used the Boston Sci-
entiﬁc Mobile Cart System IVUS to perform these measurements.
Results: We identiﬁed 233 lesions: 115 in left lower extremity (LLE)
and 118 in the right lower extremity (RLE). The CEAP scores in the LLE
were C1: 0; C2: 35; C3: 40; C4: 15; C5: 20; and C6: 6; with the most common
site being the proximal common iliac vein in 37.4% (20.86% females and 16.5%
males). The CEAP scores in the RLE were C1: 0; C2: 31; C3: 42; C4: 14; C5:
23; and C6: 7; and the most common site was in the middle external iliac vein
in 31.35% (20.4% females and 11.01% males). The least common site of the
NIVL in the LLE was in the distal external iliac vein in 2.6% (2.6% females
and 0% males). In the RLE, the least common site of NIVL was also in the
distal external vein 7.62% (5.93% females and 1.69% males). No correlation be-
tween age, laterality, gender, or CEAP score were noted.
Conclusions: This analysis gives an insight into understanding the
anatomical location of the NIVL, which is often an undiagnosed cause of
lower extremity venous diseases. Despite multiple questions yet to be
answered, the results give an insight to clinicians and researches to guide
their treatment and research.
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Objectives: Visceral artery aneurysms (VAA) are rare, with poorly char-
acterized natural history and treatment outcomes. We reviewed the long-term
outcomes of conservative management of splenic and renal aneurysms.
Methods: A retrospective review of patients with conservatively
managed or treated VAA from 2000 to 2013 was conducted. Characteristics
and outcomes were compared.
Results: We identiﬁed 150 patients with VAA: 64 were conservatively
managed and 86 underwent open or endovascular repair. Demographics,
comorbidities, anatomy, and presentation are detailed in the Table. The
mean follow-up for observed VAA was 37.5 6 42.1 months, and 53 splenic
and 11 renal aneurysms were followed up for a mean of 34.6 6 40.3
months. Splenic aneurysms ranged in diameter from 7.7 to 45.9 mm,
with 56.6% being at the hilum, and 81.1% were heavily calciﬁed speciﬁcally
in the observed group. Most patients were women beyond the childbearing
age. Renal aneurysms ranged in diameter from 6.3 to 30.2 mm and were
primarily localized to the proximal renal artery (54.5%). Most patients
were older females. During the follow-up period, the mean diameter of
splenic and renal aneurysms remained unchanged. No patients in the
observed group required an intervention for elective or urgent repair. No
aneurysm-related mortality was identiﬁed in the observed group for both
renal and splenic aneurysms
Conclusions: Splenic and renal aneurysms can be conservatively
managed even at a diameter >15 mm, especially in older patients and post-
menopausal women. The growth rate in patients aged >65 years is very
slow, and rupture or need for elective repair are rare over long-term follow-up.>Eastern Vascular Society
